WEBSITE BSE:539122 NSE: BODHTREE Inc. Year: 1982 Industry: IT - Software My Bucket: Add Stock
Last updated: 11:16
No Notes Added Yet
Bodhtree Consulting Ltd. is a global IT services and consulting company founded in 1998, with its headquarters in Sterling, Virginia, and a significant presence in Hyderabad, India. The company specializes in digital transformation, offering a comprehensive suite of services including cloud solutions, advanced analytics, enterprise application services, cybersecurity, and digital customer experience. Bodhtree serves a diverse clientele across various industries such as healthcare, life sciences, manufacturing, education, government, and financi...Read More
Bodhtree Consulting Ltd. is a global IT services and consulting company founded in 1998, with its headquarters in Sterling, Virginia, and a significant presence in Hyderabad, India. The company specializes in digital transformation, offering a comprehensive suite of services including cloud solutions, advanced analytics, enterprise application services, cybersecurity, and digital customer experience. Bodhtree serves a diverse clientele across various industries such as healthcare, life sciences, manufacturing, education, government, and financial services . Recognized for its commitment to quality, Bodhtree has achieved CMMI Level 5 appraisal and holds certifications like ISO 9001:2008 and ISO 27001:2013. The company employs over 800 professionals globally and operates offices in the United States, Singapore, and India. Its client portfolio includes Fortune 500 companies and small to medium-sized enterprises, reflecting its adaptability and broad service capabilities . Bodhtree\'s service offerings encompass a wide range of solutions such as Salesforce and Oracle CRM implementations, data warehousing, artificial intelligence, robotic process automation, and application integration. The company also provides industry-specific solutions like cloud-based geotagging for government projects, CRM systems for educational institutions, and API solutions for pharmaceutical enterprises . ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹35 Cr.
Stock P/E -27.6
P/B 1.5
Current Price ₹16
Book Value ₹ 10.7
Face Value 10
52W High ₹47.6
Dividend Yield 0%
52W Low ₹ 13.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Mar 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2 | 0 | 12 | 0 | 1 | 4 | 1 | 2 | 4 | 6 |
| Other Income | -0 | 1 | 0 | 0 | 0 | -0 | 0 | 0 | 1 | 0 |
| Total Income | 2 | 1 | 12 | 0 | 1 | 4 | 1 | 2 | 5 | 6 |
| Total Expenditure | 27 | 0 | 12 | 1 | 2 | 3 | 2 | 2 | 4 | 5 |
| Operating Profit | -25 | 1 | -0 | -1 | -1 | 1 | -1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -24 | -0 | -0 | -1 | -1 | 1 | -1 | 0 | 1 | 1 |
| Provision for Tax | 0 | 0 | 1 | 0 | -0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Tax | -25 | -0 | -1 | -1 | -1 | 1 | -1 | 0 | 0 | 1 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 |
| Profit After Adjustments | -25 | -0 | -1 | -1 | -1 | 1 | -1 | 0 | 0 | 1 |
| Adjusted Earnings Per Share | -8 | -0 | -0.3 | -0.3 | -0.3 | 0.4 | -0.3 | 0.2 | 0.2 | 0.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 43 | 46 | 79 | 114 | 116 | 141 | 146 | 104 | 39 | 17 | 6 | 13 |
| Other Income | 1 | 2 | 1 | 0 | 3 | 10 | 9 | 2 | 3 | 1 | 1 | 1 |
| Total Income | 43 | 48 | 80 | 115 | 119 | 151 | 154 | 106 | 43 | 17 | 7 | 14 |
| Total Expenditure | 40 | 43 | 72 | 100 | 97 | 135 | 133 | 100 | 67 | 17 | 8 | 13 |
| Operating Profit | 4 | 5 | 8 | 14 | 22 | 17 | 22 | 6 | -24 | -0 | -1 | 1 |
| Interest | 2 | 2 | 3 | 2 | 4 | 3 | 2 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 2 | 1 | 1 | 6 | 6 | 7 | 5 | 5 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 4 | 6 | 13 | 7 | 16 | 0 | -26 | -2 | -1 | 1 |
| Provision for Tax | 0 | -0 | 2 | 2 | 4 | 3 | 3 | -0 | 0 | 1 | 0 | 0 |
| Profit After Tax | 1 | 2 | 3 | 4 | 8 | 4 | 13 | 1 | -26 | -2 | -1 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 1 | 2 | 3 | 4 | 8 | 4 | 13 | 1 | -26 | -3 | -1 | 0 |
| Adjusted Earnings Per Share | 0.2 | 0.7 | 1 | 1.4 | 2.6 | 1.4 | 4.2 | 0.2 | -8.5 | -0.9 | -0.5 | 0.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -65% | -61% | -47% | -18% |
| Operating Profit CAGR | 0% | NAN% | NAN% | NAN% |
| PAT CAGR | 0% | NAN% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -38% | 46% | -1% | -2% |
| ROE Average | -9% | -22% | -9% | 1% |
| ROCE Average | -8% | -15% | -4% | 6% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 27 | 38 | 41 | 44 | 50 | 54 | 67 | 68 | 42 | 15 | 14 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 2 | 0 | 3 | 2 | 8 | 4 | 2 | 4 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -1 | -0 | -0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 |
| Total Current Liabilities | 24 | 25 | 49 | 61 | 97 | 66 | 69 | 72 | 71 | 1 | 2 |
| Total Liabilities | 52 | 64 | 90 | 108 | 150 | 129 | 141 | 141 | 116 | 15 | 16 |
| Fixed Assets | 4 | 5 | 14 | 15 | 18 | 12 | 7 | 2 | 2 | 0 | 0 |
| Other Non-Current Assets | 12 | 22 | 15 | 16 | 9 | 21 | 27 | 27 | 27 | 0 | 0 |
| Total Current Assets | 36 | 38 | 61 | 77 | 123 | 96 | 107 | 112 | 88 | 15 | 15 |
| Total Assets | 52 | 64 | 90 | 108 | 150 | 129 | 141 | 141 | 116 | 15 | 16 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 0 | 0 | 0 | 3 | -5 | -4 | -5 | -13 | -4 | 7 |
| Cash Flow from Operating Activities | -3 | 2 | 14 | -4 | 17 | 10 | 1 | -6 | 7 | -3 | -2 |
| Cash Flow from Investing Activities | -1 | -11 | -8 | -8 | -2 | -13 | 4 | 1 | 0 | 0 | 1 |
| Cash Flow from Financing Activities | 5 | 9 | -5 | 12 | -15 | 4 | -6 | -3 | 2 | 14 | 0 |
| Net Cash Inflow / Outflow | 1 | 0 | 0 | 0 | 0 | 1 | -1 | -8 | 9 | 11 | -1 |
| Closing Cash & Cash Equivalent | 3 | 0 | 0 | 0 | 3 | -4 | -5 | -13 | -4 | 7 | 7 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.21 | 0.65 | 0.99 | 1.4 | 2.64 | 1.44 | 4.24 | 0.23 | -8.53 | -0.93 | -0.48 |
| CEPS(Rs) | 0.77 | 1.12 | 1.43 | 3.28 | 4.54 | 3.66 | 5.75 | 1.77 | -8.39 | -0.83 | -0.45 |
| DPS(Rs) | 0 | 0 | 0.32 | 0.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 9.83 | 12.96 | 14.69 | 14.3 | 16.33 | 17.7 | 21.93 | 22.16 | 13.63 | 5.52 | 5.11 |
| Core EBITDA Margin(%) | 7.54 | 7.64 | 9.08 | 12.31 | 16.6 | 4.61 | 8.9 | 3.97 | -70.94 | -5.56 | -26.44 |
| EBIT Margin(%) | 5.3 | 8.15 | 8.67 | 7.45 | 13.84 | 6.87 | 11.79 | 1.5 | -63.29 | -3.18 | -19.01 |
| Pre Tax Margin(%) | 1.44 | 2.77 | 5.47 | 5.64 | 10.82 | 4.92 | 10.73 | 0.43 | -66.22 | -10.28 | -20.73 |
| PAT Margin (%) | 1.31 | 3.83 | 3.51 | 3.76 | 6.99 | 3.14 | 8.96 | 0.69 | -66.76 | -14.88 | -20.87 |
| Cash Profit Margin (%) | 4.89 | 6.58 | 5.03 | 8.82 | 12.02 | 7.96 | 12.14 | 5.23 | -65.62 | -13.35 | -19.8 |
| ROA(%) | 1.2 | 3.04 | 3.58 | 4.35 | 6.29 | 3.19 | 9.67 | 0.51 | -20.42 | -3.74 | -8.14 |
| ROE(%) | 2.12 | 5.74 | 7.27 | 10.15 | 17.24 | 8.49 | 21.41 | 1.07 | -47.7 | -8.72 | -9.01 |
| ROCE(%) | 6.54 | 8.64 | 13.94 | 14.82 | 25.08 | 14.57 | 22.68 | 1.88 | -35.42 | -1.52 | -8.06 |
| Receivable days | 134.01 | 179.94 | 145.03 | 152.82 | 257.12 | 230.84 | 196.41 | 303.78 | 706.18 | 766.44 | 387.52 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 29.77 | 26.96 | 33.82 | 9.98 | 15 | 4.43 | 81.22 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 1.5 | 1.82 | 3.31 | 1.61 | 1.22 | 0.86 | 0.86 | 0.3 | 0 | 4 |
| Dividend Yield(%) | 0 | 0 | 1.21 | 1.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.6 | 1.39 | 1 | 1.44 | 0.77 | 0.57 | 0.46 | 0.7 | 0.53 | 0.59 | 7.87 |
| EV/Core EBITDA(x) | 6.78 | 12.8 | 9.82 | 11.51 | 4.08 | 4.84 | 3.09 | 11.68 | -0.85 | -35.73 | -43.85 |
| Net Sales Growth(%) | -8.31 | 7.92 | 70.43 | 45.37 | 1.57 | 21.62 | 2.95 | -28.44 | -62.24 | -57.91 | -63.31 |
| EBIT Growth(%) | -51.99 | 65.76 | 81.32 | 25.03 | 88.55 | -39.59 | 76.56 | -90.92 | -1698.5 | 97.89 | -119.51 |
| PAT Growth(%) | -82.58 | 215.91 | 55.9 | 56.02 | 88.58 | -45.28 | 193.62 | -94.46 | -3735.31 | 90.62 | 48.56 |
| EPS Growth(%) | -82.58 | 215.9 | 51.58 | 41.07 | 88.58 | -45.28 | 193.62 | -94.46 | -3735 | 89.1 | 48.55 |
| Debt/Equity(x) | 0.43 | 0.29 | 0.2 | 0.51 | 0.24 | 0.31 | 0.19 | 0.26 | 0.3 | 0 | 0.04 |
| Current Ratio(x) | 1.51 | 1.53 | 1.24 | 1.26 | 1.27 | 1.45 | 1.55 | 1.55 | 1.24 | 20.72 | 6.91 |
| Quick Ratio(x) | 1.54 | 1.53 | 1.24 | 1.26 | 1.27 | 1.45 | 1.55 | 1.55 | 1.24 | 20.72 | 6.91 |
| Interest Cover(x) | 1.37 | 1.52 | 2.71 | 4.1 | 4.59 | 3.51 | 11.18 | 1.4 | -21.62 | -0.45 | -11.04 |
| Total Debt/Mcap(x) | 0 | 0.21 | 0.11 | 0.15 | 0.15 | 0.25 | 0.22 | 0.3 | 1 | 0 | 0.01 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 41.22 | 41.22 | 93.17 | 93.17 | 93.17 | 93.17 | 93.17 | 73.17 | 73.17 | 73.17 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.5 | 0.5 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 |
| Public | 58.28 | 58.28 | 6.77 | 6.77 | 6.77 | 6.77 | 6.77 | 26.78 | 26.78 | 26.78 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.82 | 0.82 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.16 | 1.16 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.59 | 0.59 | 0.59 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 | 2.19 | 2.19 | 2.19 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
